These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15205351)

  • 1. Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity.
    Dolan ME; Newbold KG; Nagasubramanian R; Wu X; Ratain MJ; Cook EH; Badner JA
    Cancer Res; 2004 Jun; 64(12):4353-6. PubMed ID: 15205351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis.
    Shukla SJ; Duan S; Badner JA; Wu X; Dolan ME
    Pharmacogenet Genomics; 2008 Mar; 18(3):253-62. PubMed ID: 18300947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping genes that contribute to daunorubicin-induced cytotoxicity.
    Duan S; Bleibel WK; Huang RS; Shukla SJ; Wu X; Badner JA; Dolan ME
    Cancer Res; 2007 Jun; 67(11):5425-33. PubMed ID: 17545624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide discovery of loci influencing chemotherapy cytotoxicity.
    Watters JW; Kraja A; Meucci MA; Province MA; McLeod HL
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11809-14. PubMed ID: 15282376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of tumor drug resistance phenotype on the dynamics of cisplatin-induced changes of rat peripheral lymphocyte chromatin structure in Guerin's carcinoma].
    Chekhun VF; Ganina KP; Kulik GI; Solianik GI; Kunskaia LN; Gushchenko NN
    Tsitol Genet; 2000; 34(5):11-7. PubMed ID: 11213624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of lipoplatin in tumor and in normal cells in vitro.
    Arienti C; Tesei A; Ravaioli A; Ratta M; Carloni S; Mangianti S; Ulivi P; Nicoletti S; Amadori D; Zoli W
    Anticancer Drugs; 2008 Nov; 19(10):983-90. PubMed ID: 18827563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
    Shukla SJ; Duan S; Wu X; Badner JA; Kasza K; Dolan ME
    Hum Genomics; 2009 Jan; 3(2):128-42. PubMed ID: 19164090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance.
    Cho JM; Manandhar S; Lee HR; Park HM; Kwak MK
    Cancer Lett; 2008 Feb; 260(1-2):96-108. PubMed ID: 18036733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
    Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
    Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo.
    Fan QL; Zou WY; Song LH; Wei W
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):189-96. PubMed ID: 15290100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [RNA interference silencing excision repair cross-complementing 1 gene and affecting cisplatin sensitivity on lung cancer cell lines].
    Shang XB; Yu ZT; Tang P; Zhang XZ
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2799-802. PubMed ID: 19080461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines.
    Igarashi T; Izumi H; Uchiumi T; Nishio K; Arao T; Tanabe M; Uramoto H; Sugio K; Yasumoto K; Sasaguri Y; Wang KY; Otsuji Y; Kohno K
    Oncogene; 2007 Jul; 26(33):4749-60. PubMed ID: 17297441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
    Stordal BK; Davey MW; Davey RA
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a peroxisome proliferator-activated receptor gamma 1 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress.
    Kim HJ; Hwang JY; Kim HJ; Choi WS; Lee JH; Kim HJ; Chang KC; Nishinaka T; Yabe-Nishimura C; Seo HG
    Clin Cancer Res; 2007 May; 13(9):2577-83. PubMed ID: 17473186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer.
    Tran HM; Shi G; Li G; Carney JP; O'Malley B; Li D
    Otolaryngol Head Neck Surg; 2004 Oct; 131(4):477-84. PubMed ID: 15467621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.